2.42
-0.0192(-0.79%)
Currency In USD
| Previous Close | 2.44 |
| Open | 2.44 |
| Day High | 2.45 |
| Day Low | 2.39 |
| 52-Week High | 6.08 |
| 52-Week Low | 1.9 |
| Volume | 154,558 |
| Average Volume | 916,750.4 |
| Market Cap | 200.55M |
| PE | -2.47 |
| EPS | -0.98 |
| Moving Average 50 Days | 2.37 |
| Moving Average 200 Days | 3.42 |
| Change | -0.02 |
If you invested $1000 in Codexis, Inc. (CDXS) 10 years ago, it would be worth $628.78 as of July 01, 2025 at a share price of $2.421. Whereas If you bought $1000 worth of Codexis, Inc. (CDXS) shares 5 years ago, it would be worth $207.44 as of July 01, 2025 at a share price of $2.421.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Codexis’ Landmark Presentations at TIDES USA Highlight Reproducibility and Process Simplification of the ECO Synthesis Platform for Manufacturing siRNA
GlobeNewswire Inc.
May 22, 2025 11:00 AM GMT
Presentations by leading siRNA CDMOs, Bachem, Nitto Avecia, and ST Pharm, highlight performance and transferability of Codexis double-stranded RNA ligases Management to host conference call today at 8 am Eastern Time to discuss data REDWOOD CITY, Ca
Codexis to Participate in Jefferies Global Healthcare Conference
GlobeNewswire Inc.
May 21, 2025 8:05 PM GMT
REDWOOD CITY, Calif., May 21, 2025 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading provider of enzymatic solutions for efficient and scalable therapeutics manufacturing, today announced the Company will attend the Jefferies Global Healt
Codexis Announces Six Presentations Featuring the ECO Synthesis Platform at TIDES USA Annual Meeting
GlobeNewswire Inc.
May 07, 2025 11:00 AM GMT
Codexis to showcase data that demonstrate the scalability and reproducibility of its enzymatic siRNA manufacturing processes Three CDMO presentations to feature data on performance of Codexis double-stranded RNA ligases Management will host a confere